Pulmicort and Arava drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pulmicort (budesonide) and Arava (leflunomide). Common drug interactions include drug hypersensitivity among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Pulmicort and Arava. It is created by eHealthMe based on reports of 86 people who take the same drugs from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Arava?

Arava has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 76,040 Arava users. Check the latest studies of Arava.



On Jul, 12, 2026

86 people who take Pulmicort and Arava together, and have interactions are studied.

Pulmicort and Arava drug interactions.

What are the common drug interactions of Pulmicort and Arava, by gender? *:

female:

  1. Drug hypersensitivity
  2. Fatigue (feeling of tiredness)
  3. Gingival cancer (cancer of gums)
  4. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  5. Neoplasm malignant (cancer tumour)
  6. Nephrolithiasis (calculi in the kidneys)
  7. Insomnia (sleeplessness)
  8. Pyrexia (fever)
  9. Back pain
  10. Fungal infection

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Asthenia (weakness)
  3. Acne (skin problems that cause pimples)
  4. Acute respiratory distress syndrome
  5. Aortic valve incompetence
  6. Aortic valve replacement
  7. Apnoea (suspension of external breathing)
  8. Arrhythmia (irregular heartbeat)
  9. Ataxia (loss of full control of bodily movements)
  10. Atrioventricular block complete (heart block complete)

What are the common drug interactions of Pulmicort and Arava, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Kidney infection
  2. Sepsis (a severe blood infection that can lead to organ failure and death)

20-29:

  1. Abdominal sepsis (abdominal infection)
  2. Acute respiratory distress syndrome
  3. Asthenia (weakness)
  4. Asthmatic crisis
  5. Blood creatine phosphokinase increased
  6. C-reactive protein increased
  7. Chest pain
  8. Death
  9. Drug exposure during pregnancy
  10. Drug ineffective

30-39:

  1. Sinusitis (inflammation of sinus)
  2. Drug exposure during pregnancy
  3. Oxygen consumption decreased
  4. Prolonged labour
  5. Adverse event
  6. Cardiac failure
  7. Chest pain
  8. Dyspnoea (difficult or laboured respiration)
  9. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  10. Interstitial lung disease

40-49:

  1. Colitis (inflammation of colon)
  2. Hypertension (high blood pressure)
  3. Irritable bowel syndrome
  4. Nausea (feeling of having an urge to vomit)
  5. Oral candidiasis (fungal infection of mouth)
  6. White blood cell count decreased
  7. Headache (pain in head)

50-59:

  1. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Neoplasm malignant (cancer tumour)
  4. Nephrolithiasis (calculi in the kidneys)
  5. Fatigue (feeling of tiredness)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Fall
  8. Fungal infection
  9. Insomnia (sleeplessness)
  10. Urethritis (inflammation of the urethra)

60+:

  1. Arthralgia (joint pain)
  2. Fall
  3. Localised infection (infection at the single location)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Oral infection
  6. Poor venous access
  7. Procedural pain
  8. Stomatitis (inflammation of mucous membrane of mouth)
  9. Tooth disorder (tooth disease)
  10. Urinary retention (the inability to completely or partially empty the bladder)

What are the existing conditions these people have? *

  1. Sinus Congestion (blockage of sinus): 9 people, 10.47%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 6.98%
  3. Hypersensitivity: 5 people, 5.81%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and Arava?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pulmicort and Arava:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Arava:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pulmicort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arava and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on budesonide and leflunomide (the active ingredients of Pulmicort and Arava, respectively), and Pulmicort and Arava (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: